No abstract available
Publication types
-
Clinical Trial, Phase I
-
Editorial
-
Comment
MeSH terms
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / genetics*
-
Breast Neoplasms / pathology
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Drug Delivery Systems*
-
Female
-
Humans
-
Lapatinib
-
Prognosis
-
Quinazolines / administration & dosage
-
Receptor, ErbB-2 / drug effects*
-
Receptor, ErbB-2 / genetics
-
Survival Analysis
-
Trastuzumab
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Quinazolines
-
Lapatinib
-
Receptor, ErbB-2
-
Trastuzumab